Vitruviae
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors (NCT07749976) | Vitruviae | 2027-01-01 |
Track Vitruviae automatically
Every clearance here is in the API, with alerts when new ones post.